Christopher Murray

Chris brings more than 20 years of experience in leading biopharmaceutical product development, manufacturing and supply chain organizations. He joined Blueprint Medicines in 2017 as Senior Vice President, Technical Operations responsible for overseeing all aspects of Chemistry, Manufacturing and Controls (CMC) for the company’s global commercial products and other compounds, as well as CMC management from early preclinical development to commercial launch and distribution. Before joining Blueprint Medicines, Chris held roles of increasing responsibility at ARIAD Pharmaceuticals, leading CMC development for multiple drugs for treatment of cancer from early preclinical stages to global commercial launch and distribution, including overseeing product development, Quality Control, process development, manufacturing, supply chain and logistics, and clinical supply. Prior to that, he managed active pharmaceutical ingredient (API) development, regulatory filings and manufacturing at Allos Therapeutics. Earlier in his career, Chris held multiple positions at Hauser, Inc. overseeing all business, technical and regulatory compliance aspects of contract R&D and manufacturing of clinical and commercial APIs and registered pharmaceutical intermediates. Chris is an inventor or co-inventor on more than 25 U.S. patents. Chris earned a B.S. in Chemistry from Hope College and a Ph.D. in Organic Chemistry from the University of Chicago.